Ali Hanif, Yamanishi Mone, Sunagawa Keigo, Kumon Mizuki, Hasi Rumana Yesmin, Aihara Mutsumi, Kawakami Ryushi, Tanaka Tamotsu
Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima 770-8513, Japan.
Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima 770-8513, Japan.
Biochim Biophys Acta Mol Cell Biol Lipids. 2024 Apr;1869(3):159452. doi: 10.1016/j.bbalip.2024.159452. Epub 2024 Jan 18.
Very long-chain fatty acids (VLCFAs) are degraded exclusively in peroxisomes, as evidenced by the accumulation of VLCFAs in patients with certain peroxisomal disorders. Although accumulation of VLCFAs is considered to be associated with health issues, including neuronal degeneration, the mechanisms underlying VLCFAs-induced tissue degeneration remain unclear. Here, we report the toxic effect of VLCFA and protective effect of C18: 1 FA in peroxisome-deficient CHO cells. We examined the cytotoxicity of saturated and monounsaturated VLCFAs with chain-length at C20-C26, and found that longer and saturated VLCFA showed potent cytotoxicity at lower accumulation levels. Furthermore, the extent of VLCFA-induced toxicity was found to be associated with a decrease in cellular C18:1 FA levels. Notably, supplementation with C18:1 FA effectively rescued the cells from VLCFA-induced apoptosis without reducing the cellular VLCFAs levels, implying that peroxisome-deficient cells can survive in the presence of accumulated VLCFA, as long as the cells keep sufficient levels of cellular C18:1 FA. These results suggest a therapeutic potential of C18:1 FA in peroxisome disease and may provide new insights into the pharmacological effect of Lorenzo's oil, a 4:1 mixture of C18:1 and C22:1 FA.
极长链脂肪酸(VLCFAs)仅在过氧化物酶体中被降解,这一点在患有某些过氧化物酶体疾病的患者体内VLCFAs的积累中得到了证实。尽管VLCFAs的积累被认为与包括神经元变性在内的健康问题有关,但VLCFAs诱导组织变性的潜在机制仍不清楚。在此,我们报告了VLCFA在过氧化物酶体缺陷的CHO细胞中的毒性作用以及C18:1脂肪酸的保护作用。我们检测了碳链长度在C20 - C26之间的饱和及单不饱和VLCFAs的细胞毒性,发现较长的饱和VLCFA在较低的积累水平下就表现出强大的细胞毒性。此外,发现VLCFA诱导的毒性程度与细胞内C18:1脂肪酸水平的降低有关。值得注意的是,补充C18:1脂肪酸可有效挽救细胞免于VLCFA诱导的凋亡,而不会降低细胞内VLCFAs的水平,这意味着只要细胞保持足够水平的细胞内C18:1脂肪酸,过氧化物酶体缺陷的细胞在存在积累的VLCFA的情况下仍可存活。这些结果表明C18:1脂肪酸在过氧化物酶体疾病中有治疗潜力,并可能为洛伦佐油(一种C18:1和C22:1脂肪酸的4:1混合物)的药理作用提供新的见解。